preloder

We are developing a mitochondrial augmentation cell-therapy platform with multiple applications including the treatment of ultra-rare pediatric diseases.

We are developing a Mitochondrial augmentation cell-therapy platform with multiple applications including the treatment of ultra-rare pediatric diseases.

Our mission is to bring revolutionary therapies to patients faster, by accelerating the science through collaboration and shared curiosity.

Our Team

Natalie Yivgi-Ohana PhD

Co-founder and CEO

Natalie received her PhD in Biochemistry at The Hebrew University in 2007, after which she performed her postdoctoral fellowship at the Weizmann Institute of Science until 2010. She has over sixteen years’ experience in mitochondrial research and founded Minovia in 2011, to help better the plight of children with mitochondrial diseases worldwide.

Noa Sher PhD

Chief Scientist

Noa is an experienced manager in the cell therapy space, and a molecular and cellular biologist by training. Noa received her PhD in Biochemistry at The Hebrew University in 2007, after which she performed her postdoctoral studies at the Whitehead Institute in Cambridge, MA and at the Technion Institute of Technology in Israel. She joined Minovia after three years as head of a research team heading preclinical development and characterization of all clinical-stage products in a leading cell therapy company.

Avigdor Shafferman PhD

Scientific Advisor

Former R&D Director and General Manager of the Israel Institute for Biological Research (IIBR), Ness-Ziona, Israel. Over 30 years of research in protein and enzyme engineering as well as in the development of viral and bacterial vaccines.

Hadass Reich PhD

QA/GMP Manager

Hadass received her PhD in Immunology from the Hebrew University and is a certified quality manager (CMQ) by the Israeli Society for Quality (ISQ) and certified internal auditors. She gained extensive experience as a manager in quality control, quality assurance, and GMP in several cell therapy pharma and biotechnology companies before joining Minovia in 2017.

Moriya Blumkin PhD

Senior Scientist

Moriya received her PhD in pharmacology at the Neuroscience Department of the Faculty of Medicine in the Technion Institute of Technology, during which she received several excellence awards. She also holds an MSc in pharmacology and organic chemistry from the Hebrew University and a BSc in organic chemistry from Bar-Ilan University. She has extensive expertise in cell culture work and imaging techniques, biochemistry, and molecular biology, as well as in a variety of biochemical analytical methodologies.

Shiri Blumenfeld Kan PhD

Senior Scientist

Shiri received her PhD in Medical Sciences at the Faculty of Medicine of the Technion Institute of Technology. Prior to joining Minovia, she worked as a flow cytometry consultant and application specialist in the Biomedical Core Facility Unit of the Faculty of Medicine.

Esraa Saadi PhD

Scientist

Esraa performed her PhD studies in the Department of Human Biology at the University of Haifa, during which she received several excellence scholarships. She had a B.Ed. from the Arab Academic College of Education and has worked as an instructor in several programs targeting children low socioeconomic sectors.

contact

Minovia Therapeutics LTD

Hasadna 3, 3902603 Tirat Hacarmel, Israel

+972-747039954

info@minovia.co.il

Copyright 2019 © Minovia Therapeutics LTD